WRA
ActiveSummary
WRA has been active since 2020 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1,000 and a net result of €50,053. Equity is shrinking by ~28.6% per year and would, assuming unchanged policy, indicatively turn negative around fiscal year 2026. Its solvency ranks better than 6% of 16810 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability100=
Solvency27▼-1
Growth32=
Track record94
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
1.9%
Return on assets
95.8%
Age of the figures
9 mo
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 6% of 16810 sector peers (2025).
NBB · sector comparisonPosition among 16810 sector peers
Solvency
better than 6%
← weakest
strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 29-05-2026, 63 days ahead of the deadline.
NBB · 5 filingsDeviation from the deadline
2025
63 d early
2024
28 d early
2023
6 d early
2022
on the day
2021
10 d late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 5 accounts on average 17 days before the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 26 July (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven monthsPosition in the running window
30-09-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, micro schema
Equity
€1,000▼ 52.4%
2024 · €2,099
Total assets
€52,231▼ 24.0%
2024 · €68,688
Net result
€50,053▼ 18.3%
2024 · €61,301
Working capital
-€5,537▲ 22.7%
2024 · -€7,161
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result€107,306-€55,478▼ 48.3%€39,146▼ 29.4%€74,842▲ 91.2%€67,806▼ 9.4%
Net result€84,951within the sector's middle half-€43,718within the sector's middle half▼ 48.5%€30,529within the sector's middle half▼ 30.2%€61,301within the sector's middle half▲ 101%€50,053within the sector's middle half▼ 18.3%
Equity€82,751within the sector's middle half-€123,269within the sector's middle half▲ 49.0%€153,798within the sector's middle half▲ 24.8%€2,099below the sector's middle half▼ 98.6%€1,000below the sector's middle half▼ 52.4%
Total assets€113,650below the sector's middle half-€142,704within the sector's middle half▲ 25.6%€164,995within the sector's middle half▲ 15.6%€68,688below the sector's middle half▼ 58.4%€52,231below the sector's middle half▼ 24.0%
Debt€30,900-€19,435▼ 37.1%€11,197▼ 42.4%€66,589▲ 495%€51,231▼ 23.1%
Working capital€73,084within the sector's middle half-€109,349within the sector's middle half▲ 49.6%€141,613within the sector's middle half▲ 29.5%-€7,161below the sector's middle half-€5,537below the sector's middle half▲ 22.7%
Solvency72.8%within the sector's middle half-86.4%above the sector's middle half▲ 13.6pp93.2%above the sector's middle half▲ 6.8pp3.1%below the sector's middle half▼ 90.2pp1.9%below the sector's middle half▼ 1.1pp
Current ratio3.37within the sector's middle half-6.63above the sector's middle half▲ 3.2613.65above the sector's middle half▲ 7.020.89below the sector's middle half▼ 12.760.89below the sector's middle half=
Return on assets (ROA)74.7%above the sector's middle half-30.6%within the sector's middle half▼ 44.1pp18.5%within the sector's middle half▼ 12.1pp89.2%above the sector's middle half▲ 70.7pp95.8%above the sector's middle half▲ 6.6pp
above
within
below
the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 9% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €52,231
Fixed assets
€6,537 ▼ 29.4%
Current assets
€45,695 ▼ 23.1%
Equity and liabilities €52,231
Equity
€1,000 ▼ 52.4%
Debt
€51,231 ▼ 23.1%
Debt's share of the balance-sheet total rises from 96.9% to 98.1%. Equity and debt are lower.
Key figures and ratios
EBITDA
€70,528▼
2024 · €77,767
Cash flow
€52,776▼
2024 · €64,227
Debt to equity
51.23▲
2024 · 31.73
Interest coverage
789.17▼
2024 · 874.58
Debt ≤ 1 year
€51,231▼
2024 · €66,589
Income taxes
€17,663▲
2024 · €16,363
A ratio outside any meaningful range has been withheld (balance sheet total €52,231, equity €1,000).
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 2,153 companies that looked in July 2024 the way this one looks now, 1.7% went bankrupt within 24 months and 96% are still going.
- Micro
- 5 to 10 years old
- solvency under 10%
- a profit of 5% of the balance sheet or more
1.7%
went bankrupt
2.2%
stopped otherwise
96%
still going
A further 0.1% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a lower bankruptcy probability: 0.2% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,340 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 1.0% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 2,153 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Non-recurring operating income76A | - | €99 | €0 | - | - | - |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €1,462 | €2,712 | €3,298 | €2,926 | €2,723 | ▼ 6.9% |
| Other operating charges640/8 | €50 | €62 | €594 | €594 | €64 | ▼ 89.2% |
| Gross operating margin9900 | €108,819 | €58,253 | €43,037 | €78,361 | €70,592 | ▼ 9.9% |
| Operating profit (loss)9901 | €107,306 | €55,478 | €39,146 | €74,842 | €67,806 | ▼ 9.4% |
| Financial income75/76B | €1 | €0 | €0 | €2,912 | €0 | ▼ 100% |
| Recurring financial income75 | €1 | €0 | €0 | €2,912 | €0 | ▼ 100% |
| Financial charges65/66B | €124 | €348 | €324 | €89 | €89 | ▲ 0.5% |
| Recurring financial charges65 | €124 | €348 | €324 | €89 | €89 | ▲ 0.5% |
| Profit (loss) for the period before taxes9903 | €107,183 | €55,130 | €38,822 | €77,665 | €67,716 | ▼ 12.8% |
| Income taxes67/77 | €22,233 | €11,412 | €8,293 | €16,363 | €17,663 | ▲ 7.9% |
| Profit (loss) for the period9904 | €84,951 | €43,718 | €30,529 | €61,301 | €50,053 | ▼ 18.3% |
| Profit (loss) for the period to be appropriated9905 | €84,951 | €43,718 | €30,529 | €61,301 | €50,053 | ▼ 18.3% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €113,650 | €142,704 | €164,995 | €68,688 | €52,231 | ▼ 24.0% |
| Fixed assets21/28 | €9,667 | €13,920 | €12,185 | €9,260 | €6,537 | ▼ 29.4% |
| Tangible fixed assets22/27 | €9,667 | €13,920 | €12,185 | €9,260 | €6,537 | ▼ 29.4% |
| Plant, machinery and equipment23 | €2,037 | €1,257 | €1,856 | €995 | €337 | ▼ 66.2% |
| Furniture and vehicles24 | €6,063 | €11,508 | €9,556 | €7,603 | €5,651 | ▼ 25.7% |
| Other tangible fixed assets26 | €1,567 | €1,155 | €774 | €661 | €549 | ▼ 17.0% |
| Current assets29/58 | €103,984 | €128,783 | €152,809 | €59,428 | €45,695 | ▼ 23.1% |
| Amounts receivable within one year40/41 | €21,681 | - | €1,777 | €1,233 | €4,337 | ▲ 252% |
| Trade receivables40 | - | - | €1,777 | €464 | €0 | ▼ 100% |
| Other amounts receivable41 | €21,681 | - | - | €769 | €4,337 | ▲ 464% |
| Current investments50/53 | - | - | €100,000 | €0 | - | - |
| Cash at bank and in hand54/58 | €73,086 | €122,861 | €45,373 | €46,950 | €28,480 | ▼ 39.3% |
| Deferred charges and accrued income490/1 | €9,217 | €5,922 | €5,660 | €11,245 | €12,877 | ▲ 14.5% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €113,650 | €142,704 | €164,995 | €68,688 | €52,231 | ▼ 24.0% |
| Equity10/15 | €82,751 | €123,269 | €153,798 | €2,099 | €1,000 | ▼ 52.4% |
| Contributions10/11 | €1,000 | €1,000 | €1,000 | €1,000 | €1,000 | = |
| Reserves13 | €81,751 | €122,269 | €152,798 | €1,099 | €0 | ▼ 100% |
| Distributable reserves133 | €81,751 | €122,269 | €152,798 | €1,099 | €0 | ▼ 100% |
| Profit (loss) carried forward14 | - | - | €0 | €0 | €0 | - |
| Amounts payable17/49 | €30,900 | €19,435 | €11,197 | €66,589 | €51,231 | ▼ 23.1% |
| Amounts payable within one year42/48 | €30,900 | €19,435 | €11,197 | €66,589 | €51,231 | ▼ 23.1% |
| Trade debts44 | €4,467 | €688 | €1,378 | €92 | €402 | ▲ 336% |
| Suppliers440/4 | €4,467 | €688 | €1,378 | €92 | €402 | ▲ 336% |
| Taxes, remuneration and social security45 | €23,233 | €11,412 | €8,293 | €5,497 | €7,500 | ▲ 36.4% |
| Taxes450/3 | €23,233 | €11,412 | €8,293 | €5,497 | €7,500 | ▲ 36.4% |
| Other amounts payable47/48 | €3,200 | €7,335 | €1,526 | €61,000 | €43,329 | ▼ 29.0% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €84,951 | €43,718 | €30,529 | €61,301 | €50,053 | ▼ 18.3% |
| + Depreciation and write-downs630 | €1,462 | €2,712 | €3,298 | €2,926 | €2,723 | ▼ 6.9% |
| Operating cash flow (approximation) | €86,413 | €46,430 | €33,826 | €64,227 | €52,776 | ▼ 17.8% |
| Investment in fixed assets (approximation) | - | -€6,966 | -€1,562 | €0 | €0 | - |
| Change in cash | - | €49,775 | -€77,488 | €1,577 | -€18,470 | ▼ 1,271% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
29-05
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
31-03
State Gazette act
Appointment: Naomi Schreurs (non-statutory director)Mandate compensation3 facts ▸
State Gazette act
Appointment: Naomi Schreurs (non-statutory director)
Mandate compensation3 facts ▸
- General meeting, 01/02/2026
- Director appointment, Naomi Schreurs (non-statutory director)
- Mandate compensation, Naomi Schreurs
2025
03-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
25-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial
Weakest financial yearnet €30,529 ▼30.2%
Net result drops to €30,529, the lowest in the series; recovery starts the following year.
31-12
Financial
Liquidity doublescurrent ratio 13.65
Current ratio from 6.63 to 13.65; short-term debt falls from €19,435 to €11,197.
31-12
Financial
Equity above €150,000Eq €153,798 ▲24.8%
3 profitable years in a row build equity to €153,798.
31-07
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
31-12
Financial
Equity above €100,000Eq €123,269 ▲49%
2 profitable years in a row build equity to €123,269.
10-08
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 10 days late
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
1 of 3 acts read
About the unread acts
Of the 3 Belgian State Gazette acts we know for this company, 1 has been read. The other 2 have not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
1 director, last change in 2026
Naomi Schreurs
CurrentNon-statutory director · since 01-02-2026
Derived from published Gazette acts. The CBE keeps the official list of function holders; we do not read it, so the two can differ.
See the function holders in the CBE →
Not every act has been read: a resignation may be missing here
2 of this company's 3 Belgian State Gazette acts have not been read yet. Appointments and resignations recorded in them are missing above: a director who resigned there may therefore still show here as sitting. The acts are in the Timeline.
Location & real-estate footprint
Registered office, Leuven · 1 establishment unit since 2020
Ground area
211 m²
Building footprint
68 m²
Volume, LiDAR
617 m³
Parcel 24051A0440/00D015, Flanders · tallest building 11.6 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
WRA
since 20202.311.261.065
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 24051A0440/00D015 | Flanders | 211 m² | 1 · 68 m² | 11.6 m · 3 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Mandate history
1 person since 2026, 1 in office
- Board
| Name | Functions and periods |
|---|---|
| Naomi Schreurs |
|
Structure & network
Connections & network
1 current directorThe network starts from this company’s directors. Other companies they run appear here as nodes.
This company
Company
Director
Shareholding
+N: links not shown yet
Click a node to look further, drag to arrange, scroll to zoom.
Similar companies · same sector, comparable size
DOKTER DAVID DERTHOO
BE 0641.627.680
Kortrijk · Eq €1,000
EVERMEA
BE 0765.404.630
Temse · Eq €1,517
SIMDA
BE 0769.312.344
Dilbeek · Eq €2,000
Apotheker Bart Peeters Klinisch Bioloog
BE 0788.356.612
Mortsel · Eq €2,000
Odontolia Lab
BE 0686.784.942
Gembloux · Eq €2,147
Of 699 companies in sector 86910 we hold annual accounts for 522. 25 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded24-11-2020
Fiscal year end31-12
Activities, NACEBEL 2025
86910Medical imaging and medical laboratories
E-invoicing
Reachable via Peppol
Peppol ID
0208:0758728258
Also
9925:BE0758728258
Registered
20-12-2024
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 30 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.